• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

638.88 -3.71 (-0.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 995,024
Open 639.24
Bid (Size) 631.57 (80)
Ask (Size) 638.88 (80)
Prev. Close 642.59
Today's Range 632.72 - 644.12
52wk Range 476.49 - 821.11
Shares Outstanding 91,779,465
Dividend Yield 0.59%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Amylyx Stock: Why the Full Pipeline Story Matters ↗
May 24, 2026
Amylyx stock has surged on pipeline progress, but investors should understand the risks and long-term catalysts driving AMLX shares 
Via MarketBeat
News headline image
Stocks making big moves this week: Toll Brothers, Booz Allen Hamilton, Strategy, Regeneron, and Micron
May 22, 2026
Check out the companies making headlines this week: Toll Brothers (NYSE:TOL): Homebuilding company Toll Brothers (NYSE:TOL) rose by 8.3% on Wednesday after t... 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
-17.7%
-17.7%
1 Month
-15.0%
-15.0%
3 Month
-18.8%
-18.8%
6 Month
-16.1%
-16.1%
1 Year
+5.9%
+5.9%

More News

Read More
News headline image
Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
May 22, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 We Question
May 22, 2026
Via StockStory
Topics Supply Chain
Unusual volume S&P500 stocks in Monday's session ↗
May 18, 2026
Via Chartmill
News headline image
Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis
May 21, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
REGN Investor Alert: Levi & Korsinsky Investigates Regeneron Pharmaceuticals, Inc. (REGN) for Potential Securities Fraud
May 20, 2026
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Why Regeneron (REGN) Shares Are Trading Lower Today
May 18, 2026
Via StockStory
What's going on in today's session: S&P500 movers ↗
May 18, 2026
Via Chartmill
Discover which S&P500 stocks are making waves on Monday. ↗
May 18, 2026
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks ↗
May 18, 2026
Via Chartmill
Which S&P500 stocks are moving before the opening bell on Monday? ↗
May 18, 2026
Via Chartmill
News headline image
Regeneron Announces Strategic Collaboration with Parabilis Medicines to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas
May 18, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma
May 15, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair
May 15, 2026
From Society For Science
Via GlobeNewswire
News headline image
3 Reasons to Sell REGN and 1 Stock to Buy Instead
May 14, 2026
Via StockStory
News headline image
Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There. ↗
May 08, 2026
Via The Motley Fool
News headline image
Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years
May 08, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Is This Biotech Stock a Buy After a Groundbreaking Approval? ↗
May 08, 2026
Via The Motley Fool
News headline image
5 Must-Read Analyst Questions From Regeneron’s Q1 Earnings Call
May 06, 2026
Via StockStory
Topics Earnings
News headline image
Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial
May 05, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Is Regeneron a Buy After the FDA Approved its Gene Therapy to Restore Hearing? ↗
May 02, 2026
Via The Motley Fool
News headline image
1 Cash-Producing Stock Worth Investigating and 2 Facing Headwinds
May 01, 2026
Via StockStory
News headline image
Regeneron Pharmaceuticals Analysts Cut Their Forecasts Following Q1 Earnings ↗
April 30, 2026
Via Benzinga
News headline image
REGN Q1 Deep Dive: Product Expansion Drives Growth, Margin Pressures Draw Scrutiny
April 30, 2026
Via StockStory

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 638.88
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 05/22/26 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 58.64B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 59B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap